Literature DB >> 34783219

Tumor-associated macrophages in osteosarcoma.

Yi Zhao1, Benzheng Zhang2, Qianqian Zhang3, Xiaowei Ma1, Helin Feng4.   

Abstract

Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. It is an aggressive tumor with a tendency to spread to the lung, which is the most common site of metastasis. Patients with advanced OS with metastases have poor prognoses despite the application of chemotherapy, thus highlighting the need for novel therapeutic targets. The tumor microenvironment (TME) of OS is confirmed to be essential for and supportive of tumor growth and dissemination. The immune component of the OS microenvironment is mainly composed of tumor-associated macrophages (TAMs). In OS, TAMs promote tumor growth and angiogenesis and upregulate the cancer stem cell-like phenotype. However, TAMs inhibit the metastasis of OS. Therefore, much attention has been paid to investigating the mechanism of TAMs in OS development and the progression of immunotherapy for OS. In this article, we aim to summarize the roles of TAMs in OS and the major findings on the application of TAMs in OS treatment.

Entities:  

Keywords:  Osteosarcoma; Tumor microenvironment; Tumor-associated macrophage

Mesh:

Year:  2021        PMID: 34783219      PMCID: PMC8593527          DOI: 10.1631/jzus.B2100029

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  62 in total

Review 1.  Progress in tumor-associated macrophage (TAM)-targeted therapeutics.

Authors:  Chayanon Ngambenjawong; Heather H Gustafson; Suzie H Pun
Journal:  Adv Drug Deliv Rev       Date:  2017-04-25       Impact factor: 15.470

Review 2.  Cancer stem cells in osteosarcoma.

Authors:  Hannah K Brown; Marta Tellez-Gabriel; Dominique Heymann
Journal:  Cancer Lett       Date:  2016-11-25       Impact factor: 8.679

3.  Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.

Authors:  Shanshan Wan; Ende Zhao; Ilona Kryczek; Linda Vatan; Anna Sadovskaya; Gregory Ludema; Diane M Simeone; Weiping Zou; Theodore H Welling
Journal:  Gastroenterology       Date:  2014-08-30       Impact factor: 22.682

4.  Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.

Authors:  Emilie P Buddingh; Marieke L Kuijjer; Ronald A J Duim; Horst Bürger; Konstantin Agelopoulos; Ola Myklebost; Massimo Serra; Fredrik Mertens; Pancras C W Hogendoorn; Arjan C Lankester; Anne-Marie Cleton-Jansen
Journal:  Clin Cancer Res       Date:  2011-03-03       Impact factor: 12.531

5.  Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Qing-Min Fan; Ying-Ying Jing; Guo-Feng Yu; Xing-Rui Kou; Fei Ye; Lu Gao; Rong Li; Qiu-Dong Zhao; Yang Yang; Zheng-Hua Lu; Li-Xin Wei
Journal:  Cancer Lett       Date:  2014-06-02       Impact factor: 8.679

6.  Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.

Authors:  Jens H W Pahl; Kitty M C Kwappenberg; Eleni M Varypataki; Susy J Santos; Marieke L Kuijjer; Susan Mohamed; Juul T Wijnen; Maarten J D van Tol; Anne-Marie Cleton-Jansen; R Maarten Egeler; Wim Jiskoot; Arjan C Lankester; Marco W Schilham
Journal:  J Exp Clin Cancer Res       Date:  2014-03-10

7.  Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours.

Authors:  Y Inagaki; E Hookway; K A Williams; A B Hassan; U Oppermann; Y Tanaka; E Soilleux; N A Athanasou
Journal:  Clin Sarcoma Res       Date:  2016-08-01

Review 8.  Macrophages and hepatocellular carcinoma.

Authors:  Zhiqiang Tian; Xiaojuan Hou; Wenting Liu; Zhipeng Han; Lixin Wei
Journal:  Cell Biosci       Date:  2019-09-26       Impact factor: 7.133

9.  CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.

Authors:  Xiaorong Lin; Lijun Chen; Yandang Yao; Ruihua Zhao; Xiuying Cui; Jun Chen; Kailian Hou; Mingxia Zhang; Fengxi Su; Jingqi Chen; Erwei Song
Journal:  Oncotarget       Date:  2015-08-21

Review 10.  New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?

Authors:  Geoffroy Danieau; Sarah Morice; Françoise Rédini; Franck Verrecchia; Bénédicte Brounais-Le Royer
Journal:  Int J Mol Sci       Date:  2019-07-31       Impact factor: 5.923

View more
  3 in total

1.  Chemical characterization of a new sulfated polysaccharide from Gracilaria chouae and its activation effects on RAW264.7 macrophages.

Authors:  Feifei Li; Kehai Liu; Kewu Liu
Journal:  J Zhejiang Univ Sci B       Date:  2022-01-15       Impact factor: 3.066

2.  Proteomic characterization of four subtypes of M2 macrophages derived from human THP-1 cells.

Authors:  Pengfei Li; Chen Ma; Jing Li; Shanshan You; Liuyi Dang; Jingyu Wu; Zhifang Hao; Jun Li; Yuan Zhi; Lin Chen; Shisheng Sun
Journal:  J Zhejiang Univ Sci B       Date:  2022-05-15       Impact factor: 5.552

3.  A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.

Authors:  Mingyi Yang; Haishi Zheng; Ke Xu; Qiling Yuan; Yirixaiti Aihaiti; Yongsong Cai; Peng Xu
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.